US Patent Issued to DOMPE FARMACEUTICI on March 24 for "Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use" (Italian Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,624, issued on March 24, was assigned to DOMPE FARMACEUTICI S.P.A. (Milan).

"Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use" was invented by Andrea Aramini (L'Aquila, Italy), Marcello Allegretti (Rome), Gianluca Bianchini (L'Aquila, Italy), Samuele Lillini (Cardito, Italy) and Mara Tomassetti (Naples, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a new co-crystal of Gabapentin, Ketoprofen and Lysine, to pharmaceutical compositions and to their use in the prevention, reduction or treatment of pain and/or inflammation."

The patent was filed on April 21, 2021,...